Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0003
Host Cell : CHO-K1 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0003 |
| Description | This cell line is engineered to stably overexpress the human VTCN1 in CHO-K1 cells. |
| Background | This gene encodes a protein belonging to the B7 costimulatory protein family. Proteins in this family are present on the surface of antigen-presenting cells and interact with ligand bound to receptors on the surface of T cells. Studies have shown that high levels of the encoded protein has been correlated with tumor progression. A pseudogene of this gene is located on chromosome 20. Multiple transcript variants encoding different isoforms have been found for this gene. |
| Target Gene | VTCN1 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | CHO-K1 |
| Host Cell Species | Cricetulus griseus (Chinese hamster) |
| Source | CHO-K1 |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | VTCN1 V-set domain containing T cell activation inhibitor 1 [ Homo sapiens ] |
| Gene Symbol | VTCN1 |
| Synonyms | VTCN1; V-set domain containing T cell activation inhibitor 1; V-set domain-containing T-cell activation inhibitor 1; B7 family member; H4; B7 superfamily member 1; B7 H4; B7H4; B7S1; B7X; FLJ22418; B7 family member, H4; T cell costimulatory molecule B7x; T-cell costimulatory molecule B7x; immune costimulatory protein B7-H4; B7-H4; B7h.5; VCTN1; PRO1291; RP11-229A19.4; |
| Gene ID | 79679 |
| Uni Prot ID | Q7Z7D3 |
| m RNA Refseq | BC065717 |
| Chromosome Location | 1p12 |
| Function | receptor binding; |
| MIM | 608162 |
A: By co-culturing Human VTCN1 Stable Cell Line-CHO with T cells and monitoring T cell activation and proliferation, the regulatory role of VTCN1 protein on T cell immune responses can be evaluated.
A: The expression level of VTCN1 protein in Human VTCN1 Stable Cell Line-CHO may be influenced by cell cycle stages, which requires validation through experiments such as flow cytometry.
A: Utilizing specific glycosylation antibodies or mass spectrometry methods can quantitatively analyze the glycosylation modification of VTCN1 protein in Human VTCN1 Stable Cell Line-CHO.
A: Yes, Human VTCN1 Stable Cell Line-CHO is highly suitable for studying the signaling mechanisms of VTCN1 protein, including its interactions with downstream effector molecules.
A: Through molecular and cellular biology experiments such as PCR, Southern blot, and cytotoxicity tests, the biosafety and genetic stability of Human VTCN1 Stable Cell Line-CHO can be assessed.
A: Yes, given the association of VTCN1 protein with immune suppression, Human VTCN1 Stable Cell Line-CHO can be utilized for anti-cancer drug screening research targeting the VTCN1 pathway.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.